Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D02XTN
|
|||
| Former ID |
DIB005025
|
|||
| Drug Name |
RO5545965
|
|||
| Indication | Schizophrenia [ICD-11: 6A20] | Phase 1 | [1] | |
| Company |
Roche
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | ClinicalTrials.gov (NCT01923025) A PET Study With RO5545965 in Healthy Male Volunteers. U.S. National Institutes of Health. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.